Intelligence Profile
Research Papers
The research on Pinealon is quite limited, with most evidence coming from Russian-language studies and no clinical trials identified in major databases.
Key Studies:
The most direct research on Pinealon appears in a 2015 Russian study examining its effects alongside Cortexin (another peptide compound) in aging rats. This animal study looked at 18-month-old rats exposed to hypoxia and hypothermia conditions, measuring behavioral and neurochemical changes. However, specific sample sizes and detailed methodology are not available from the abstract alone.
Another 2015 Russian study evaluated Pinealon's potential anti-aging effects in patients with chronic multiple conditions and brain disorders in remission, but again, detailed study parameters are not accessible from the limited information available.
Two additional 2015 Russian studies examined peptides' geroprotective (anti-aging) effects, with one specifically looking at work ability indices as an outcome measure, though it's unclear if Pinealon was specifically tested in these studies.
Related Peptide Research:
While not directly about Pinealon, several studies have examined similar short peptides:
- A 2020 study (33 participants) investigated EDR peptide's role in Alzheimer's disease, exploring gene expression and protein synthesis mechanisms
- A 2019 study examined how the tripeptide Glu-Asp-Arg interacts with DNA in the presence of different ions
- A 2021 study looked at a different tetrapeptide (Asp-Arg-Glu-Leu) and its antioxidant properties
Evidence Limitations:
The research base for Pinealon is extremely thin. Most studies are published in Russian journals with limited international visibility, sample sizes are not clearly reported, and no randomized controlled trials were identified. The available evidence consists primarily of animal studies and observational research in elderly populations, making it difficult to draw firm conclusions about Pinealon's efficacy or safety in humans.
This information is for educational purposes only and should not be considered medical advice. Consult with a healthcare provider before considering any experimental treatments.